← Leaderboards
Sandi Alexander Kwee
Queen'S Medical Center
$3,199,221
Attributed
$4,286,675
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $586.7K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,286,675 · 3
By mechanism
R01$3,520,195 · 2
R21$766,480 · 1
Top collaborators
- Gordon Shoji Okimoto6 shared
Most similar at Queen'S Medical Center
Same institution · by research overlap
- Gordon Shoji Okimoto$1,237,454
Others in their field
Top investigators on “Characteristics”
- Lawrence Corey · Fred Hutchinson Cancer Center$259,409,773
- Jeffrey P Krischer · University Of South Florida$234,914,225
- Constance Ann Benson · University Of California, San Diego$187,977,954
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$136,053,061
- Peter B. Gilbert · Fred Hutchinson Cancer Center$118,817,242
Research focus
CharacteristicsTumorUnited StatesX-Ray Computed TomographyMalignant NeoplasmsClinical TrialsPositron-Emission TomographyResponseImageTreatment ResponseSignal TransductionBaseMolecularMetabolicSignal PathwaySourceCancer EtiologyDetectionPrimary Carcinoma Of The Liver CellsFluorodeoxyglucose Positron Emission TomographyFluorodeoxyglucosePerformanceIncidenceEvaluation
Grant awards (12)
Evaluation of treatment predictors reflecting beta-catenin activation in hepatocellular carcinoma$1
R01 · FY2025 · CA · contact PI
Evaluation of treatment predictors reflecting beta-catenin activation in hepatocellular carcinoma$586,680
R01 · FY2023 · CA · contact PI
Evaluation of treatment predictors reflecting beta-catenin activation in hepatocellular carcinoma$238,598
R01 · FY2022 · CA · contact PI
Evaluation of treatment predictors reflecting beta-catenin activation in hepatocellular carcinoma$520,008
R01 · FY2021 · CA · contact PI
Functional Genomics and Molecular Imaging of Liver Disease and Cancer$325,386
R01 · FY2016 · CA · contact PI
Functional Genomics and Molecular Imaging of Liver Disease and Cancer$411,672
R01 · FY2015 · CA · contact PI
Functional Genomics and Molecular Imaging of Liver Disease and Cancer$85,787
R01 · FY2014 · CA · contact PI
Functional Genomics and Molecular Imaging of Liver Disease and Cancer$435,949
R01 · FY2013 · CA · contact PI
Functional Genomics and Molecular Imaging of Liver Disease and Cancer$464,110
R01 · FY2012 · CA · contact PI
Functional Genomics and Molecular Imaging of Liver Disease and Cancer$452,004
R01 · FY2011 · CA · contact PI
Treatment Effects on Tumor 18F-Choline Metabolism in Advanced Prostate Cancer$383,240
R21 · FY2010 · CA · contact PI
Treatment Effects on Tumor 18F-Choline Metabolism in Advanced Prostate Cancer$383,240
R21 · FY2009 · CA · contact PI